Citadel Advisors’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Buy |
|
|||||
|
2025
Q1 | $2.35M | Buy |
|
|||||
|
2024
Q4 | $2.32M | Buy |
|
|||||
|
2024
Q3 | $2.45K | Sell |
|
|||||
|
2024
Q2 | $400K | Sell |
|
|||||
|
2024
Q1 | $1.75M | Sell |
|
|||||
|
2023
Q4 | $6.75M | Buy |
|
|||||
|
2023
Q3 | $1.1M | Buy |
|
|||||
|
2023
Q2 | $130K | Sell |
|
|||||
|
2023
Q1 | $140K | Buy |
|
|||||
|
2022
Q4 | $59.2K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.26M | Sell |
|
|||||
|
2021
Q4 | $2.65M | Buy |
|
|||||
|
2021
Q3 | $2.78M | Sell |
|
|||||
|
2021
Q2 | $5.33M | Buy |
|